About Cerevast Therapeutics, Inc.
Cerevast Therapeutics is developing a revolutionary treatment for acute ischemic stroke using a combination therapy, known as sonothrombolyis, or SonoLysis for short. Founded in 2009 and headquartered in Redmond, Washington, Cerevast will provide emergency room practitioners with the tools they need to treat this devastating disease. Specialties Biomedical Research & Development
Cerevast Therapeutics, Inc. Job Openings
Create job profile to receive interview calls for your dream job
Create Job Alert Kick Start! your career with best matching jobs
Location
X